Survival in BRAF-mutant metastatic melanoma in the real-world setting: results from the Dutch Melanoma Treatment Registry

被引：0

作者：

Schouwenburg, M. ^{[1
]}

Jochems, A. ^{[1
]}

Aarts, M. ^{[2
]}

van den Berkmortel, F. ^{[3
]}

van den Eertwegh, A. ^{[4
]}

Franken, M. ^{[5
]}

Groenewegen, G. ^{[6
]}

de Groot, J-W. ^{[7
]}

Haanen, J. B. A. G. ^{[8
]}

Hospers, G. ^{[9
]}

Kapiteijn, E. ^{[10
]}

Koornstra, R. ^{[11
]}

Kruit, W. ^{[12
]}

Louwman, M. ^{[13
]}

Piersma, D. ^{[14
]}

van Rijn, R. ^{[15
]}

Ten Tije, A. J. ^{[16
]}

Vreugdenhil, G. ^{[17
]}

Wouters, M. ^{[18
]}

van der Hoeven, J. ^{[1
]}

机构：

[1] LUMC, Med Oncol, Leiden, Netherlands

[2] MUMC, Med Oncol, Maastricht, Netherlands

[3] Atrium Med Ctr Parkstad, Med Oncol, Heerlen, Netherlands

[4] Vrije Univ Amsterdam Med Ctr, Med Oncol, Amsterdam, Netherlands

[5] Erasmus Univ, Inst Med Technol Assessment, Med Technol Assessment, Rotterdam, Netherlands

[6] Univ Med Ctr Utrecht, Med Oncol, Utrecht, Netherlands

[7] Isala Klin, Med Oncol, Zwolle, Netherlands

[8] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands

[9] Univ Hosp Groningen UMCG, Med Oncol, Groningen, Netherlands

[10] LUMC, Clin Oncol, Leiden, Netherlands

[11] Radboud Univ Nijmegen, Med Ctr Nijmegen, Med Oncol, Nijmegen, Netherlands

[12] Erasmus MC, Internal Oncol, Daniel den Hoed Canc Ctr, Rotterdam, Netherlands

[13] Netherlands Comprehens Canc Org IKNL, Epidemiol, Utrecht, Netherlands

[14] MST, Med Oncol, Enschede, Netherlands

[15] Med Ctr Leeuwarden, Med Oncol, Leeuwarden, Netherlands

[16] Amphia Ziekenhuis, Med Oncol, Breda, Netherlands

[17] Maxima Med Ctr, Med Oncol, Eindhoven, Netherlands

[18] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Surg Oncol, Amsterdam, Netherlands

来源：

ANNALS OF ONCOLOGY | 2016年 / 27卷

关键词：

D O I：

10.1093/annonc/mdw379.34

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1139P

引用

页数：1

共 50 条

[21] Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment Registry
Jochems, Anouk
Bastiaannet, Esther
Aarts, Maureen J. B.
van Akkooi, Alexander C. J.
van den Berkmortel, Franchette W. P. J.
Boers-Sonderen, Marye J.
van den Eertwegh, Alfonsus J. M.
de Glas, Nienke G.
de Groot, Jan Willem B.
Haanen, John B. A. G.
Hospers, Geke A. P.
van der Hoeven, Jacobus J. M.
Piersma, Djura
van Rijn, Rozemarijn S.
Suijkerbuijk, Karijn P. M.
ten Tije, Albert J.
van der Veldt, Astrid A. M.
Vreugdenhil, Gerard
van Zeijl, Michiel C. T.
Kapiteijn, Ellen
Wouters, Michel W. J. M.
[J]. JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (07) : 1031 - 1038
[22] Sequencing of Targeted Treatment and Immunotherapy in Advanced BRAF-Mutant Melanoma
Devlin, Olivia
Oladipo, Olabode
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (12) : 2295 - +
[23] Treatment of BRAF-Mutant Melanoma: The Role of Vemurafenib and Other Therapies
Jang, S.
Atkins, M. B.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (01) : 24 - 31
[24] Treatment patterns and overall survival (OS) in patients with advanced BRAF mutant (mt) melanoma treated with immunotherapy and targeted therapy (TT) in a real-world setting
Atkins, M. B.
Julian, C.
Secrest, M. H.
Lee, J.
Abajo, A. M.
McKenna, E.
[J]. ANNALS OF ONCOLOGY, 2020, 31 : S1446 - S1446
[25] Identifying the optimum first-line therapy in BRAF-mutant metastatic melanoma
Ziogas, Dimitrios C.
Konstantinou, Frosso
Bouros, Spyros
Gogas, Helen
[J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (01) : 53 - 62
[26] Cost-effectiveness of encorafenib with binimetinib in unresectable or metastatic BRAF-mutant melanoma
Trouiller, Jean-Baptiste
Nikolaidis, Georgios F.
Macabeo, Berengere
Meyer, Nicolas
Gerlier, Laetitia
Schlueter, Max
Laramee, Philippe
[J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2024, 25 (04): : 641 - 653
[27] Combination Treatment of Patients with BRAF-Mutant Melanoma: A New Standard of Care
Ester Simeone
Antonio M. Grimaldi
Lucia Festino
Vito Vanella
Marco Palla
Paolo A. Ascierto
[J]. BioDrugs, 2017, 31 : 51 - 61
[28] Combination Treatment of Patients with BRAF-Mutant Melanoma: A New Standard of Care
Simeone, Ester
Grimaldi, Antonio M.
Festino, Lucia
Vanella, Vito
Palla, Marco
Ascierto, Paolo A.
[J]. BIODRUGS, 2017, 31 (01) : 51 - 61
[29] BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies
Spagnolo, Francesco
Ghiorzo, Paola
Orgiano, Laura
Pastorino, Lorenza
Picasso, Virginia
Tornari, Elena
Ottaviano, Vincenzo
Queirolo, Paola
[J]. ONCOTARGETS AND THERAPY, 2015, 8 : 157 - 168
[30] A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases
Harding, James J.
Catalanotti, Federica
Munhoz, Rodrigo R.
Cheng, Donavan T.
Yaqubie, Amin
Kelly, Nicole
Mcdermott, Gregory C.
Kersellius, Romona
Merghoub, Taha
Lacouture, Mario E.
Carvajal, Richard D.
Panageas, Katherine S.
Berger, Michael F.
Rosen, Neal
Solit, David B.
Chapman, Paul B.
[J]. ONCOLOGIST, 2015, 20 (07): : 789 - 797

← 1 2 3 4 5 →